Cabotegravir is recommended in combination with safer sex practices for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually-acqu...

Martin Friede, coordinator of the World Health Organisation Initiative for Vaccine Research, said Africa had produced many scientific resea...

Following a review of the FDA decision, the South African Health Products Regulatory Authority (SAHPRA) said in a statement that it had dec...

The shot was also 100% effective in preventing illness among trial participants in South Africa, where a new variant called B1351 is domina...

SII, the world's biggest vaccine manufacturer, has partnered with AstraZeneca, the Gates Foundation and the Gavi vaccine alliance to make u...

The shots developed by UK-based drugmaker AstraZeneca and Oxford University are being manufactured at the Serum Institute of India, the wor...

The not-yet peer reviewed study by Pfizer and scientists from the University of Texas Medical Branch indicated the vaccine was effective in...

Several global trials of the vaccine, AZD1222, were put on hold last month after an unexplained illness in a study participant. While most ...

The deal comes with a potential revision linked to FY17 performance along with customary adjustment (within the price band of 250 mn Rand a...

The collaboration will focus on oncology, central nervous system, women's health, cardiovascular, ophthalmology and other speciality produc...

Zameer Agrawal, director, Roselabs Biosciences Ltd, said, "We have recently entered into a $20 million contract supply deal with a Brazilia...

Cipla Medpro is a South African affiliate of Cipla. The companies enjoy a long-standing business relationship spanning two decades.

Cipla decides to put on hold its $220-million acquisition plan of the third-largest South African drugmaker Cipla Medpro due to valuation i...

Cipla said on Wednesday it will buy 51% of Cipla Medpro for about $220 million, valuing the beleaguered South African company at about $440...

The country's second-largest pharmaceuticals company, Cipla, is in talks with an international health group to expand its contraceptive pil...

Ranbaxy Laboratories, India's largest drugmaker by sales, said on Tuesday its unit had launched atorvastatin, generic form of Pfizer Inc's ...

Aurobindo Pharma, Cipla and Ranbaxy, have received a lion's share of over 85 per cent in the US government's latest fiscal funding for AIDS...